Circulating tumor cells in localized prostate cancer: Isolation, cultivation In Vitro and relationship to T-stage and gleason score

Anticancer Research

Volumn 34, Issue 7, 2014, Pages 3641-3646

  Kolostova, Katarina ^a   Broul, Marek ^b   Schraml, Jan ^b   Cegan, Martin ^b   Matkowski, Rafal ^c,d   Fiutowski, Marek ^e   Bobek, Vladimir ^a,c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Masaryk Hospital   (Czech Republic)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

^d Dolnoslaskie Centrum Onkologii Wroclaw   (Poland)

^e REGIONAL SPECIALIST HOSPITAL   (Poland)

Author keywords

Biomarker; Blood biopsy; Circulating tumor cells; CTC; Cultivation; Culturing; MetaCell; Minimal residual disease; Prostate cancer; Virgin CTC

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CIRCULATING TUMOR CELL; DEVICES; FILTRATION; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOLECULARLY TARGETED THERAPY; PROSTATE CANCER; SINGLE CELL ANALYSIS; SOLUTION AND SOLUBILITY; SURFACE PROPERTY; AGED; BLOOD; BLOOD BIOPSY; CANCER GRADING; COHORT ANALYSIS; CTC; CULTIVATION; CULTURING; CYTOLOGY; METACELL; METHODOLOGY; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL CULTURE; TUMOR EMBOLISM; VIRGIN CTC;

BIOLOGICAL MARKER;

BIOMARKER; BLOOD BIOPSY; CIRCULATING TUMOR CELLS; CTC; CULTIVATION; CULTURING; METACELL; MINIMAL RESIDUAL DISEASE; PROSTATE CANCER; VIRGIN CTC;

AGED; COHORT STUDIES; CYTOLOGICAL TECHNIQUES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84906324445     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Kolostova K, Pinterova D, Hoffman RM and Bobek V: Circulating human prostate cancer cells from an orthotopic mouse model rapidly captured by immunomagnetic beads and imaged by GFP expression. Anticancer Res 31: 1535-1539, 2011.
2. Sterzynska K, Kempisty B, Zawierucha P and Zabel M: Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines. Folia Histochem Cytobiol 50: 534-541, 2012.
3. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J and Weinberg RA: The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715, 2008.
4. Papsidero LD, Kuriyama M, Wang MC, Horoszewicz J, Leong SS, Valenzuela L, Murphy GP and Chu TM: Prostate antigen: a marker for human prostate epithelial cells. J Natl Cancer Inst 66: 37-42, 1981.
5. Elgamal AA, Ectors NL, Sunardhi-Widyaputra S, Van Poppel HP, Van Damme BJ and Baert LV: Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation. J Urol 156: 464-468, 1996.
6. Henttu P, Liao SS and Vihko P: Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology 130: 766-772, 1992.
7. Scher HI, Jia X, de Bono JS, Fleisher M, Pienta KJ, Raghavan D and Heller G: Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a re-analysis of IMMC38 trial data. Lancet Oncol 10: 233-239, 2009.
8. Halabi S, Small EJ, Kantoff PW, Kattan MW, Kaplan EB, Dawson NA, Levine EG, Blumenstein BA and Vogelzang NJ: Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. J Clin Oncol 21: 1232-1237, 2003.
9. Lin HK, Zheng S, Williams AJ, Balic M, Groshen S, Scher HI, Fleisher M, Stadler W, Datar RH, Tai YC and Cote RJ: Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin. Cancer Res 16: 5011-5018, 2010.
10. Diamond E, Lee GY, Akhtar NH, Kirby BJ, Giannakakou P, Tagawa ST and Nanus DM: Isolation and characterization of circulating tumor cells in prostate cancer. Front Oncol 11: 131, 2012
11. Pierga JY, Bidard FC, Mathiot C, Brain E, Delaloge S, Giachetti S, de Cremoux P, Salmon R, Vincent-Salomon A and Marty M: Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clin. Cancer Res 14: 7004-7010, 2008.
12. Menen R, Zhao M, Zhang L, Hassanein MK, Bobek V, Kolostova K, Bouvet M and Hoffman RM: Comparative chemosensitivity of circulating human prostate cancer cells and primary cancer cells. Anticancer Res 32: 2881-2884, 2012.